| Up
2005P-0244:
Determine that Decadron (dexamethasone USP) 1.5 mg Tablet Strength
was not Removed from the Market for Safety and Efficacy Reasons
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 06/20/2005
|
| 06/20/2005
|
| Private Industry
|
| ECR Pharmaceuticals
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| David S. Caskey
|
|
|
|
|
| ACK1
|
| 06/20/2005
|
| 06/20/2005
|
| Private Industry
|
| HFA-305 to ECR Pharmaceuticals
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Gloria Ortega
|
|
|
|
|
| N1
|
|
|
| 12/27/2005
|
| FDA
|
| FDA
|
| 12/28/2005
|
| 76851-76851
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| SHUREN, JEFFREY
|
|
|
| LET1
|
| 12/29/2005
|
| 12/29/2005
|
| Federal
Government
|
| HFD-007 to ECR Pharmaceuticals
|
|
|
|
|
|
|
| pdf,
Attachment
|
|
|
|
|
|
|
|
|
| Signature:
|
| Janice L. Weiner
| |
Top | Up
Page last updated
January 23, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
